You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 248 No. 22, December 10, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORT
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Human Babesiosis

Clinical and Therapeutic Considerations

Myles E. Gombert, MD; Ellie J. C. Goldstein, MD; Jorge L. Benach, PhD; Marvin J. Tenenbaum, MD; Edgar Grunwaldt, MD; Mark H. Kaplan, MD; Laverne K. Eveland, PhD

JAMA. 1982;248(22):3005-3007.


Abstract

During a two-month period, six patients from eastern Long Island were identified as having Babesia microti infection. Diagnosis was based on characteristic blood smears, hamster inoculation, or both. Symptom duration ranged from 19 to 24 days in five patients. The sixth patient, who had previously undergone splenectomy, had a more severe and prolonged illness. No specific therapy was administered to five patients. The patient who had had a splenectomy was treated with chloroquine, quinine, pentamidine, and exchange transfusions. There were no deaths. It appears that most cases of human B microti infection can be effectively managed with symptomatic and supportive care.

(JAMA 1982;248:3005-3007)



Author Affiliations

From the Division of Infectious Diseases, Department of Medicine (Drs Gombert and Goldstein), and the Department of Microbiology and Immunology (Dr Eveland), State University of New York-Downstate Medical Center, Brooklyn; the Infectious Disease Division, Department of Medicine, North Shore University Hospital, Manhasset (Drs Tenenbaum and Kaplan) and Shelter Island (Dr Grunwaldt), NY; and the New York State Department of Health, State University of New York, Stonybrook (Dr Benach).


Footnotes

Reprint requests to State University of New York-Downstate Medical Center, 450 Clarkson Ave, Box 56, Brooklyn, NY 11203 (Dr Gombert).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antiparasitic Agent Atovaquone
Baggish and Hill
Antimicrob. Agents Chemother. 2002;46:1163-1173.
FULL TEXT  

Tick-Borne Pulmonary Disease: Update on Diagnosis and Management
Faul et al.
Chest 1999;116:222-230.
ABSTRACT | FULL TEXT  

Human Babesiosis in New York State: Review of 139 Hospitalized Cases and Analysis of Prognostic Factors
White et al.
Arch Intern Med 1998;158:2149-2154.
ABSTRACT | FULL TEXT  

Tick-Borne Diseases in the United States
Spach et al.
NEJM 1993;329:936-947.
FULL TEXT  

Case 28-1993- A 63-Year-Old Man with Fever, Sweats, and Shaking Chills
Marcus and Mattia
NEJM 1993;329:194-199.
FULL TEXT  

Lyme Disease and Its Neurologic Complications
Finkel
Arch Neurol 1988;45:99-104.
ABSTRACT  

Babesiosis and Infection with Human Immunodeficiency Virus (HIV)
BENEZRA et al.
ANN INTERN MED 1987;107:944-944.
ABSTRACT  

Rift Valley Fever Caused the Fifth Plague of Egypt and That of 1977
Shimshony
JAMA 1986;256:1444-1444.
ABSTRACT  

Babesiosis in Wisconsin: A New Focus of Disease Transmission
Steketee et al.
JAMA 1985;253:2675-2678.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.